Search for: "MOLECULAR SYSTEMS, INC." Results 41 - 60 of 183
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Jul 2015, 3:08 am by Mark Summerfield
  In the same month, a team led by Feng Zhang at the Broad Institute, Inc and MIT reported similar success using CRISPR to edit human genes.Which brings me to the main topic of this post. [read post]
29 May 2012, 8:23 am
Allan Goldstein, Professor and Chairman Emeritus, Department of Biochemistry and Molecular Biology at The George Washington University School of Medicine, Washington, D.C., stated regarding these clinical trials with TB4: "these results are extremely encouraging and are consistent with results of TB4 administration in other Central Nervous System injuries, as well as in cardiovascular injury models. [read post]
31 Oct 2011, 7:30 am
Patently Obvious: Why The District Court's Ruling in Association for Molecular Pathology v. [read post]
11 Mar 2015, 9:40 am by Dennis Crouch
Roche Molecular Systems, Inc., 131 S.Ct. 2188 (2011) (ownership under Bayh-Dole) Association for Molecular Pathology v. [read post]
2 Nov 2010, 4:29 am by admin
Roche Molecular Systems Inc., U.S., No. 09-1159, cert. granted 11/1/10 ). [read post]
10 Apr 2012, 10:57 am by Dennis Crouch
In Association for Molecular Pathology (AMP) v. [read post]
26 Feb 2016, 1:20 pm by David Jensen
” Weissman’s technique uses a monoclonal antibody that attaches to the CD47 protein on cancer cells them from hiding from the patient’s immune system. [read post]
2 Oct 2019, 10:00 pm
Supreme Court decided Henry Schein, Inc. v. [read post]
3 Aug 2011, 5:11 am by Lawrence B. Ebert
Patentable 'inventions' in this area include molecular features, modifications that enhance compound efficacy and gene-specific RNAi targets, among others. [read post]
12 Mar 2013, 6:47 am by Sarah Erickson-Muschko
In the Buffalo Law Journal, Jeremy Oczek summarizes the legal issues in, and industries affected by, three intellectual property law cases pending before the Court this Term: (1) Association for Molecular Pathology v. [read post]
21 Nov 2011, 11:53 am by Stephen Jenei
Brief for the American Civil Liberties Union  Brief for AARP and the Public Patent Foundation Amicus Briefs in Support of Neither Party Brief for the International Association for the Protection of Intellectual Property Brief for the United States of America  Brief for Roche Molecular Systems, Inc. et al. [read post]
3 Jun 2022, 2:14 pm by Ana Popovich
Caris Life Sciences, Inc., a “molecular science company headquartered in Texas,” agreed to pay $2,886,674.86 “to resolve allegations that it violated the False Claims Act in an alleged nationwide scheme to improperly bill Medicare for laboratory tests known as ‘Caris Molecular Intelligence’ and the ‘ADAPT Biotargeting System. [read post]
1 Jul 2021, 8:48 am by Lisa Larrimore Ouellette
Roche Molecular Systems, Inc., 563 U.S. 776 (2011) (re-affirming assignment priority rules in cases of conflicting patent assignments).DissentOn the other hand, if the approach announced by the dissent takes hold, or is extended to other doctrinal areas, the resulting legal changes could be felt on a massive scale. [read post]
16 Feb 2012, 8:07 am by Stephanie Figueroa
Roche Molecular Systems, Inc. - This case involved the interpretation of two competing assignments executed before the invention was conceived or reduced to practice. [read post]